AstraZeneca has announced a $15bn investment in China by 2030 to expand manufacturing and R&D.

GC Therapeutics has appointed Kate Haviland as Board Chair.

Genentech has announced positive topline results from a phase 2 trial of CT-388, its investigational therapy to treat obesity ...

Tamer Mohamed, founder and CEO at Aspect Biosystems added: “Our partnership with Novo Nordisk combines more than a century of ...

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

GlaxoSmithKline (GSK) has announced that Arexvy, its respiratory syncytial virus (RSV) vaccine, has received expanded ...

Sanofi and Regeneron’s Dupixent (dupilumab) has received positive final draft guidance from the National Institute for Health ...

In response to ISPOR’s recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group, suggests that ...

Emotive has appointed Terri Cooper as Chair of the Board and Mark Swindell as Non-Executive Director.

Ipsen has appointed Pierrick Lefranc as Executive Vice President (EVP) Technical Operations, as well as a member of its Executive Leadership Team (ELT).

Sanofi has announced that its amlitelimab has shown positive results in the treatment of patients 12 years and older with ...

Eisai and Biogen’s Supplemental Biologics License Application (sBLA) for Leqembi (lecanemab) subcutaneous autoinjector (SC-AI) has been accepted by the US FDA under Priority Review to treat early ...